Conclusions: Primary series vaccination with BNT162b2 and BBIBP-CorV was effective at preventing COVID-19 among HCWs, most of whom had previous infection, during a period of mainly Delta circulation. Our results support the utility of COVID-19 primary vaccine series, a...
Factors motivating the decision to vaccinate changed from safety-related concerns for the primary series to perceived need for the booster. It is key to address economic and health access barriers to achieve equitable COVID-19 vaccine uptake and continued protection against COVID-19. 展开 ...
Find the latest COVID-19 news and guidance in Medscape'sCoronavirus Resource Center. Welcome toCases in Deprescribing. In this series, I present a clinical scenario drawn from my own practice. I will share with you what I plan to do, but I am more interested in crowdsourcing a response f...
BNT162b2 boosters as the third vaccination induced robust immunogenicity against both Omicron BA.1 and BA.5 subvariants in all primary series regimens. Fractional COVID-19 vaccination schedules alleviate limited vaccine supplies and may reduce reactogenicity while providing similar immunogenicity and ...
In the phase III clinical trial of the Moderna vaccine, the efficacy of the two-dose vaccine series was similar to the Pfizer-BioNTech vaccine series. The trial found that the Moderna vaccine series demonstrated 94.1% efficacy for preventing COVID-19 illness, including severe disease, in particip...
AstraZeneca recentlyannouncedpositive results from an interim analysis of clinical trials testing its COVID-19 vaccine, AZD1222, in the UK and Brazil. Specifically, AZD1222 met the primary endpoint of preventing COVID-19, and no hospitalizations or severe cases of the disease were reporte...
Since December 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a global pandemic named coronavirus disease-19 (COVID-19) and
For each COVID-19 vaccination shot (first, second, and third), within-individual changes in menstrual cycle length up to the fourth postvaccination cycle were evaluated. Among the 7,376 and 6,873 participants who had the first and second COVID-19 vaccine doses in different menstrual cycles,...
We selected 13 convalescent individuals that had experienced symptomatic Covid-19 infection with either WA1 virus or the Beta or Gamma variants. Serum, plasma and PBMC were isolated at each respective clinical center. The selection of individuals was based on the availability of samples collected at...
COVID-19: when you can refuse to treat a patient due to inadequate PPE The implications for nurses of RCN guidance on care provision and inadequate PPE 23 Apr 2020 Interventions to improve the mental health and well-being of children and young people ...